1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Helicobacter pylori Infections Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Helicobacter pylori Infections Clinical Trials by Region
2.2.2 Average Enrollment of Helicobacter pylori Infections Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Helicobacter pylori Infections Treatment, 2019

3. Region wise Helicobacter pylori Infections Clinical Trials
3.1 Asia Pacific Helicobacter pylori Infections Clinical Trials by Country
3.2 Europe Helicobacter pylori Infections Clinical Trials by Country
3.3 North America Helicobacter pylori Infections Clinical Trials by Country
3.4 Middle East and Africa Helicobacter pylori Infections Clinical Trials by Country
3.5 South and Central America Helicobacter pylori Infections Clinical Trials by Country

4. Helicobacter pylori Infections Clinical Trial Trends
4.1 Start Year wise Helicobacter pylori Infections Clinical Trials
4.2 Phase wise Helicobacter pylori Infections Clinical Trials
4.3 Trial Status wise Helicobacter pylori Infections Clinical Trials
4.4 Trial Type wise Helicobacter pylori Infections Clinical Trials

5. Helicobacter pylori Infections Average Enrollment Trends
5.1 Average Enrollment in Helicobacter pylori Infections Trials by Year
5.2 Average Enrollment in Helicobacter pylori Infections Trials by Phase
5.3 Average Enrollment in Helicobacter pylori Infections Trials by Status
5.4 Average Enrollment in Helicobacter pylori Infections Trials by Type of Trial

6. Companies Participating in Helicobacter pylori Infections Clinical Trials
6.1 Helicobacter pylori Infections Trials by Sponsor Type
6.2 Helicobacter pylori Infections Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Helicobacter pylori Infections Trials- Phase 1
7.2 Helicobacter pylori Infections Trials- Phase 2
7.3 Helicobacter pylori Infections Trials- Phase 3
7.4 Helicobacter pylori Infections Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Helicobacter pylori Infections Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Figure 5: Europe – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Figure 7: North America – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Figure 9: Helicobacter pylori Infections Clinical Trials by Phase
Figure 10: Helicobacter pylori Infections Clinical Trials by Trial Status
Figure 11: Helicobacter pylori Infections Clinical Trials by Type
Figure 12: Helicobacter pylori Infections Clinical Trials by Sponsor Type
Figure 13: Helicobacter pylori Infections Clinical Trials by Leading Sponsors
Figure 14: Helicobacter pylori Infections Average Enrollment by Phase
Figure 15: Helicobacter pylori Infections Average Enrollment by Trial Status
Figure 16: Helicobacter pylori Infections Average Enrollment by Type
Figure 17: Helicobacter pylori Infections- Average Enrolment by Type of Sponsors
Figure 18: Helicobacter pylori Infections- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Helicobacter pylori Infections Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Table 5: Europe – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Table 7: North America – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Helicobacter pylori Infections Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Helicobacter pylori Infections Average Enrollment by Phase
Table 15: Helicobacter pylori Infections Average Enrollment by Trial Status
Table 16: Helicobacter pylori Infections Average Enrollment by Type
Table 17: Helicobacter pylori Infections- Average Enrolment by Type of Sponsors
Table 18: Helicobacter pylori Infections- Enrolment by Leading Sponsors

Companies mentioned